The Attention-Deficit/Hyperactivity Disorder Medication-Related Attitudes of Patients and Their Parents
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Patient perspectives represent an increasingly important focus in clinical trials of medical treatments for pediatric mental health conditions. This paper describes the development and initial testing of a short, easy to complete, condition specific, measure of patients' and their parents' attitudes regarding drugs used for the treatment of their attention-deficit/hyperactivity disorder (ADHD)--the Southampton ADHD Medication Behaviour and Attitudes scale. On the basis of an initial qualitative study and pilot data, subscales were constructed for both the child and parent versions covering perceived costs and benefits of treatment, patient stigma, and resistance to treatment. The parent version had additional subscales for parental stigma, treatment inconsistency, and flexibility. Factor and reliability analysis of data from 356 parents and 123 of their children supported the distinction between these subscale domains. Children were aged between 5 and 18 years (mean age 10.95 years). Parent and child scores were correlated, although as in previous research parents rated ADHD medications as having more benefits and children rated them as having more costs. The Southampton ADHD Medication Behaviour and Attitudes scale represents a useful addition to the growing portfolio of patient-reported outcomes for ADHD treatments. Future research should focus on the scales value in predicting treatment adherence as it impacts on medication effectiveness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sirey, J. A., Bruce, M. L., Alexopoulos, G. S., Perlick, D. A., Friedman, S. J., & Meyers, B. S. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.12.1615 · Cited by 796 · cited 1×
“…consistently identified as a strong predictor of non-adherence across a wide range of conditions and treatment regimens, including: antiepileptic medications (Buck et al. 1997); antidepressants (Ayalon et al. 2005, Sirey et al. 2001); and medication for schizophrenia (Freudenreich et al. 2004).”
European clinical guidelines for hyperkinetic disorder ? first upgrade
Taylor, E., D�pfner, M., Sergeant, J., Asherson, P., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Rothenberger, A., Sonuga-Barke, E., et al. (2004) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-004-1002-x · Cited by 682 · cited 1×
“Multi-modal treatment combining psychosocial and pharmacological approaches is recommended (Taylor et al. 2004).”
Self-citationStimulant treatment over five years: adherence, effectiveness, and adverse effects
Charach, A., Ickowicz, A., & Schachar, R. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200405000-00009 · Cited by 315
Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD
THIRUCHELVAM, D., CHARACH, A., & SCHACHAR, R. J. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200108000-00014 · Cited by 172 · cited 1×
“Adolescent refusal to take ADHD medication is well documented (Stein et al. 2001, Weiss et al. 2000), as are the high drop out rates from stimulant treatment (Charach et al. 2004, Firestone 1982, Thiruchelvam et al. 2001).”
Riley, A. W., Spiel, G., Coghill, D., Döpfner, M., Falissard, B., Lorenzo, M. J., Preuss, U., Ralston**, S. J., & ADORE Study Group* (2006) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-006-1006-9 · Cited by 156
Factors associated with children's adherence to stimulant medication
Firestone, P. (1982) · American Journal of Orthopsychiatry · doi:10.1111/j.1939-0025.1982.tb01431.x · Cited by 143
Cited by
Stigma in attention deficit hyperactivity disorder
Mueller, A. K., Fuermaier, A. B. M., Koerts, J., & Tucha, L. (2012) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-012-0085-3 · Cited by 306
“Levels of reported costs were significantly related to both children’s perception of stigma and to resistance to ADHD medication intake (Harpur et al. 2008).”
BackgroundMethodInfluentialStigmatization of ADHD: A Developmental Review
Lebowitz, M. S. (2016) · Journal of Attention Disorders · doi:10.1177/1087054712475211 · Cited by 192
“…5 to 18 years who had been prescribed ADHD medications found that perceptions of stigma surrounding ADHD treatment were significantly associated with perceiving their medication to have more “costs” (e.g., negative side effects) and with resistance to taking their medication (Harpur et al., 2008).”
BackgroundAdvances in understanding and treating ADHD
Antshel, K. M., Hargrave, T. M., Simonescu, M., Kaul, P., Hendricks, K., & Faraone, S. V. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-72 · Cited by 140
Metadata
- Authors
- Harpur, R. A., Thompson, M., Daley, D., Abikoff, H., & Sonuga-Barke, E. J. S.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2008-10
- Volume
- 18
- Issue
- 5
- Pages
- 461-473
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2053565547
- Cited by
- 36
- References
- 6
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Attention-Deficit/Hyperactivity Disorder Medication-Related Attitudes of Patients and Their Parents. https://app.cochat.ai/papers/10.1089/cap.2008.023
- The paper
- Harpur, R. A., Thompson, M., Daley, D., Abikoff, H., & Sonuga-Barke, E. J. S. (2008). The Attention-Deficit/Hyperactivity Disorder Medication-Related Attitudes of Patients and Their Parents. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2008.023
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.